Target volume changes through high-dose-rate brachytherapy for cervical cancer when evaluated on high resolution (3.0 Tesla) magnetic resonance imaging

Practical Radiation Oncology

Volumn 2, Issue 4, 2012, Pages

  Sun, Wenqing ^a   Bhatia, Sudershan K ^a   Jacobson, Geraldine M ^a   Flynn, Ryan T ^a   Kim, Yusung ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CISPLATIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CLINICAL ARTICLE; DRUG MEGADOSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HIGH DOSE RATE BRACHYTHERAPY; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPTICAL RESOLUTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; UTERINE CERVIX CANCER;

EID: 84866511635     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2012.03.012     Document Type: Article

References (28)

1. Kim Y, Xia J, Su n W, et al. Tandem and ovoids brachytherapy for cervical cancer when evaluated by high resolution (3.0 Tesla) MRI. Medl Phys 2010, 37:3348.
2. Kim Y, Xia J On the dosimetric impact of dose sculpting optimization in high resolution (3.0 tesla) MRI-guided HDR brachytherapy for GYN cancer: when are the benefits maximized?. Medl Phys 2010, 37:3196.
3. Pötter R, Georg P, Dimopoulos JC, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011, 100:116-123.
4. Zwahlen D, Jezioranski J, Chan P, et al. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys 2009, 74:1157-1164.
5. Viswanathan AN, Erickson BA Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2010, 76:104-109.
6. Eifel PJ, Morris M, Wharton JT, Oswald MJ The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994, 29:9-16.
7. Homesley HD, Raben M, Blake DD, et al. Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. Surg Gynecol Obstet 1980, 150:529-531.
8. Nam TK, Nah BS, Choi HS, et al. Assessment of tumor regression by consecutive pelvic magnetic resonance imaging and dose modification during high-dose-rate brachytherapy for carcinoma of the uterine cervix. Cancer Res Treat 2005, 37:157-164.
9. Gong QY, Tan LT, Romaniuk CS, Jones B, Brunt JN, Roberts N Determination of tumour regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability. Br J Radiol 1999, 72:62-72.
10. Huh SJ, Park W, Han Y Interfractional variation in position of the uterus during radical radiotherapy for cervical cancer. Radiother Oncol 2004, 71:73-79.
11. Mayr NA, Magnotta VA, Ehrhardt JC, et al. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1996, 35:915-924.
12. Wang JZ, Mayr NA, Zhang D, et al. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy. Cancer 2010, 116:5093-5101.
13. Huang Z, Mayr NA, Yuh WT, et al. Predicting outcomes in cervical cancer: a kinetic model of tumor regression during radiation therapy. Cancer Res 2010, 70:463-470.
14. Mayr NA, Yuh WT, Taoka T, et al. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. AJR Am J Roentgenol 2006, 187:65-72.
15. Mayr NA, Taoka T, Yuh WT, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002, 52:14-22.
16. Dimopoulos JC, Schirl G, Baldinger A, Helbich TH, Pötter R MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009, 185:282-287.
17. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000, 48:201-211.
18. Kim Y, Muruganandham M, Modrick JM, Bayouth JE Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer. Int J Radiat Oncol Biol Phys 2011, 80:947-955.
19. Potter R, Kirisits C, Fidarova EF, et al. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 2008, 47:1325-1336.
20. Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005, 74:235-245.
21. Pötter R, Dimopoulos J, Georg P, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007, 83:148-155.
22. Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006, 78:67-77.
23. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999, 43:57-66.
24. Jürgenliemk-Schulz IM, Tersteeg RJ, Roesink JM, et al. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Radiother Oncol 2009, 93:322-330.
25. Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results. Int J Radiat Oncol Biol Phys 2006, 65:624-630.
26. Dimopoulos JC, De Vos V, Berger D, et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiotherapy and oncology. Radiother Oncol 2009, 91:166-172.
27. Kataoka M, Isoda H, Maetani Y, et al. MR imaging of the female pelvis at 3 Tesla: evaluation of image homogeneity using different dielectric pads. J Magn Reson Imaging 2007, 26:1572-1577.
28. Liu Y, Flynn R, Kim Y, et al. Dynamic-shield intensity-modulated brachytherapy (IMBT) for cervical cancer. Int J Radiat Oncol Biol Phys 2011, 81:S201.